EFM
E Fund Management Portfolio holdings
AUM
$2.1B
This Quarter Return
+1.57%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.61B
AUM Growth
+$36.4M
(+2.3%)
Cap. Flow
+$105M
Cap. Flow
% of AUM
6.47%
Top 10 Holdings %
Top 10 Hldgs %
61.46%
Holding
387
New
81
Increased
131
Reduced
147
Closed
19
Top Buys
| 1 |
ASE Group
ASX
|
$25.3M |
| 2 |
Microsoft
MSFT
|
$12.9M |
| 3 |
NVIDIA
NVDA
|
$11.9M |
| 4 |
Apple
AAPL
|
$9.18M |
| 5 |
Amazon
AMZN
|
$7.47M |
Top Sells
| 1 |
Sea Limited
SE
|
$24.3M |
| 2 |
Advanced Micro Devices
AMD
|
$16.8M |
| 3 |
TSMC
TSM
|
$8M |
| 4 |
Weibo
WB
|
$2.43M |
| 5 |
Pinduoduo
PDD
|
$2.4M |
Sector Composition
| 1 | Consumer Discretionary | 40.2% |
| 2 | Technology | 29.79% |
| 3 | Communication Services | 9.9% |
| 4 | Healthcare | 5.71% |
| 5 | Real Estate | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
MacroGenics
MGNX
$121M
| $245K | 0.02% |
+16,667
| New | +$245K |
|
302
Centene
CNC
$14.8B
| $244K | 0.02% |
3,110
+410
| +15% | +$32.2K |
|
303
Cencora
COR
$57.2B
| $244K | 0.02% |
+1,003
| New | +$244K |
|
304
Take-Two Interactive
TTWO
$44.1B
| $244K | 0.02% |
1,641
-37
| -2% | -$5.49K |
|
305
West Pharmaceutical
WST
$17.9B
| $243K | 0.02% |
+613
| New | +$243K |
|
306
Avidity Biosciences
RNA
$6.12B
| $242K | 0.02% |
9,497
-979
| -9% | -$25K |
|
307
Agilent Technologies
A
$35.5B
| $240K | 0.01% |
1,650
+115
| +7% | +$16.7K |
|
308
Xencor
XNCR
$594M
| $240K | 0.01% |
+10,839
| New | +$240K |
|
309
Zscaler
ZS
$42.1B
| $239K | 0.01% |
1,241
-36
| -3% | -$6.94K |
|
310
GlobalFoundries
GFS
$18.4B
| $239K | 0.01% |
4,582
-132
| -3% | -$6.88K |
|
311
iShare MSCI Eurozone ETF
EZU
$7.78B
| $237K | 0.01% |
+4,640
| New | +$237K |
|
312
BellRing Brands
BRBR
$5.27B
| $236K | 0.01% |
+3,995
| New | +$236K |
|
313
4D Molecular Therapeutics
FDMT
$302M
| $234K | 0.01% |
+7,351
| New | +$234K |
|
314
Sana Biotechnology
SANA
$759M
| $234K | 0.01% |
23,361
| – | – |
|
315
ResMed
RMD
$39.4B
| $233K | 0.01% |
+1,177
| New | +$233K |
|
316
Zimmer Biomet
ZBH
$20.8B
| $228K | 0.01% |
+1,728
| New | +$228K |
|
317
ConocoPhillips
COP
$118B
| $227K | 0.01% |
1,782
-93
| -5% | -$11.8K |
|
318
Union Pacific
UNP
$132B
| $227K | 0.01% |
922
+99
| +12% | +$24.3K |
|
319
Mettler-Toledo International
MTD
$26.1B
| $225K | 0.01% |
169
+2
| +1% | +$2.66K |
|
320
Molina Healthcare
MOH
$9.6B
| $224K | 0.01% |
+546
| New | +$224K |
|
321
Align Technology
ALGN
$9.59B
| $224K | 0.01% |
684
-80
| -10% | -$26.2K |
|
322
Cogent Biosciences
COGT
$1.83B
| $224K | 0.01% |
33,308
+17,897
| +116% | +$120K |
|
323
Keysight
KEYS
$28.4B
| $223K | 0.01% |
1,429
-42
| -3% | -$6.57K |
|
324
Zentalis Pharmaceuticals
ZNTL
$123M
| $222K | 0.01% |
14,083
-5,257
| -27% | -$82.9K |
|
325
Lowe's Companies
LOW
$146B
| $222K | 0.01% |
+870
| New | +$222K |
|